Global Molecular Biology Enzymes and Kits & Reagents Market Forecasted Robust Growth by 2030, Driven by Advancements in Genomic Research
01 févr. 2024 09h11 HE
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Molecular Biology Enzymes and Kits & Reagents Market by Product, Application and End Users, Regional Outlook - Forecast up to 2030" report...
Global Enzyme Inhibitor Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on PPIs, Protease, Reverse Transcriptase, Aromatase, Kinase, Neuraminidase, & Statins
18 oct. 2022 06h33 HE
|
Research and Markets
Dublin, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The "Enzyme Inhibitor Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global enzyme inhibitor market is expected...
Insights on the PCR Technologies and Global Markets to 2026 - by Product Type, Technology, Application and Region
02 sept. 2021 06h43 HE
|
Research and Markets
Dublin, Sept. 02, 2021 (GLOBE NEWSWIRE) -- The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global...
Molecular Biology Enzymes & Kits & Reagents Market by Product, Application, End-user and Region - Global Forecast to 2026
15 juin 2021 06h13 HE
|
Research and Markets
Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic...
Global Molecular Biology Enzymes, Kits, and Reagents Market Report 2021-2028
24 mai 2021 06h53 HE
|
Research and Markets
Dublin, May 24, 2021 (GLOBE NEWSWIRE) -- The "Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, End User, and...
Outlook on the HIV Drugs Global Market to 2027 - Opportunity Analysis and Industry Forecast
19 janv. 2021 05h58 HE
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "Global HIV Drugs Market By Medication Class, Non-nucleoside Reverse Transcriptase Inhibitors and HIV Integrase Strand Transfer Inhibitors: Opportunity...